Bifidobacterium Lactis HN019 Supplementation for Prevention of Influenza Infection in Healthy Adults

PHASE3UnknownINTERVENTIONAL
Enrollment

426

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Influenza
Interventions
DIETARY_SUPPLEMENT

Bifidobacterium lactis HN019

B. lactis HN019 (5 billion cfu / day) sachet, consumed once per day for 12 weeks

DIETARY_SUPPLEMENT

Placebo

Placebo sachet, consumed once per day for 12 weeks

Trial Locations (2)

33134

RECRUITING

Clinical Research of South Florida, Coral Gables

48307

RECRUITING

Remedica, LLC, Rochester

Sponsors
All Listed Sponsors
collaborator

Danisco

INDUSTRY

collaborator

Sprim Advanced Life Sciences

OTHER

lead

Fonterra Research Centre

INDUSTRY